Effectiveness and safety of endoscopic submucosal dissection for ulcerative colitis associated neoplasia

Effectiveness and safety of endoscopic submucosal dissection for ulcerative colitis associated neoplasia - ESD for UC associated neoplasia

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000035293

Enrollment

Registered

2018-12-20

Start date

2016-10-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative colitis associated neoplasia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patient who has the history of ulcerative colitis was enrolled in this study. 2)Patient has Intra-mucosal neoplasia 3)Distant metastasis and lymph node metastasis were excluded by CT or ultrasonography 4)Identifiable demrcation confirmed by pathological diagnosis of specimens taken from adjacent mucosa to the lesion 5)Remission or mild active UC (Mayo Endoscopic scoring 0-1) 6)Patient who has better understanding and regarded as suitable for this study

Exclusion criteria

Exclusion criteria: Patient regarded as unsuitable for this study

Design outcomes

Primary

Measure	Time frame
Effectiveness of pathological diagnosis of ESD specimen comparing to forceps biopsy.	—

Secondary

Measure	Time frame
Safety(intra-prcedual perforation, delayed perforation, post-procedural bleeding), Efficacy(operation duration, ratio ofcomplete resection and local recurrence)	—

Countries

Japan

Contacts

Public ContactKenichi Mizuno

Graduate School of Medical and Dental Sciences, Niigata University Division of Gastroenterology and Hepatology

kenken_mjp@yahoo.co.jp0252272207

Outcome results